About us
Pipeline
Target Markets
Our Technologies
Partnering
News, Media & Events
Investors
Careers
Contact
Home
News, Media & Events
Media Coverage
Destiny Pharma podcast presentation to Vox Markets ‘New funds will progress two lead clinical assets towards Phase 3 trials’
Destiny Pharma podcast presentation to Vox Markets ‘New funds will progress two lead clinical assets towards Phase 3 trials’